Ironwood Pharmaceuticals Inc (IRWD)

Net profit margin

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Net income (ttm)	US$ in thousands	-1,002,242	-952,288	-917,292	181,978	175,065	167,572	173,100	527,323	528,448	530,278	508,856	142,757	106,176	110,830	97,055	84,134	21,505	-41,846	-236,845	-298,508
Revenue (ttm)	US$ in thousands	429,548	419,194	422,558	411,359	404,724	414,655	405,461	404,251	391,925	391,475	387,138	375,652	361,301	370,922	366,956	377,722	370,977	375,368	345,294	323,795
Net profit margin		-233.32%	-227.17%	-217.08%	44.24%	43.26%	40.41%	42.69%	130.44%	134.83%	135.46%	131.44%	38.00%	29.39%	29.88%	26.45%	22.27%	5.80%	-11.15%	-68.59%	-92.19%

December 31, 2023 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $-1,002,242K ÷ $429,548K
= -233.32%

Ironwood Pharmaceuticals Inc has experienced a significant decline in net profit margin over the last few quarters, with negative margins in the most recent quarters. The net profit margin has been consistently negative in the last four quarters, indicating that the company has been experiencing losses that exceed its revenue. This trend suggests that the company may be facing financial challenges or operating inefficiencies that are impacting its profitability. It is important for stakeholders to closely monitor the company's financial performance and assess the effectiveness of its strategies to improve profitability and financial sustainability.